James D Thomas

5PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersMolecular targetsGene and molecular therapyMedical devicesGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 01, 2024
Multiplexed screening reveals how cancer-specific alternative polyadenylation shapes tumor growth in vivo.

Austin M Gabel, Andrea E Belleville, James D Thomas

|Aug 10, 2021
Integrative oncogene-dependency mapping identifies RIT1 vulnerabilities and synergies in lung cancer.

Athea Vichas, Amanda K Riley, Naomi T Nkinsi

|Sep 15, 2020
The sustained expression of Cas9 targeting toxic RNAs reverses disease phenotypes in mouse models of myotonic dystrophy type 1.

Ranjan Batra, David A Nelles, Daniela M Roth

|Feb 23, 2020
HNRNPA1-induced spliceopathy in a transgenic mouse model of myotonic dystrophy.

Moyi Li, Yan Zhuang, Ranjan Batra

|Jan 09, 2020
RNA isoform screens uncover the essentiality and tumor-suppressor activity of ultraconserved poison exons.

James D Thomas, Jacob T Polaski, Qing Feng

Pageof 1